| Contact Details |
|---|
Voronoi
Category:
Venture
Main Business Area
Voronoi is a biotech company that develops novel kinase inhibitors and target protein degraders. They have about 120 employees, each specialized in Synthesis/Structural Biology, Biology, and AI/Molecular Modeling, etc, who have great expertise in kinase inhibitors.
Find out more companies
Related products
-
-
-
-
-
VentureAprogen
Their main modalities include SDR-Grafting, Recombinant Protein Fusion, CHIMPS Bispecific Antibodies, SHOCAP Bispecific Antibodies, and Bitargeting Receptor-Antibody Hybrid